The University of Liverpool has joined the European Technology Platform for Nanomedicine (ETPN) and will host a major nanomedicine conference next year, further strengthening the institution’s strategic research links with collaborators and networks in Europe.
Nanotherapeutics represents an ever-expanding field that has made a significant impact on healthcare over the past few decades and has, more recently, supported the fight against SARS-CoV-2 in the development of vaccines.
The ETPN has been acting as the official think tank of nanomedicine in Europe for the last 15 years, building an active community of more than 125 stakeholders from 27 European countries.
Membership of the ETPN expands the University’s connections within nanomedicine. The University was a founding member of the British Society for Nanomedicine and university academics continue in leadership roles within society. This interaction, along with Liverpool’s role as a key partner in a number of European projects and infrastructures, continues to drive forwards nanomedicine throughout the UK and across Europe.
Dr Neill Liptrott, from the Institute of Systems, Molecular and Integrative Biology, who led the application said: “I’m delighted that the University of Liverpool is now an official member of ETPN. This is a result of many years of collaboration with various member organisations of the ETPN, as well as EUNCL, and will highlight the fantastic work that has been ongoing at Liverpool, for some time.”
The University has also been invited to host Nanomedicine Europe 2023 (NME23), a unique in-person conference bringing together scientists, technology providers, entrepreneurs, industry, clinicians, and policy makers in June next year.
Dr Liptrott added: “As Europe’s largest conference dedicated to nanomedicine, it will be a great honour to bring it to Liverpool, welcome old friends and collaborators, as well as new, to the city, and show them what we have to offer.”
Co-chair of the British Society for Nanomedicine and reader in Chemistry at Liverpool, Tom McDonald said: “I am very excited for the British Society for Nanomedicine to be co-organising next year’s NME23 along with ETPN, it is an excellent opportunity for us to showcase the nanomedicine research that has been ongoing across the UK, as well as re-affirm our links into European Nanomedicine organisations.”
ETPN Chair, Professor Ray Schiffelers, said: “We are delighted to welcome the University of Liverpool to the ETPN. The University of Liverpool has been and continues to be, strategically involved in many projects aimed at developing, and improving nanomedicines. After so many years of fruitful collaborations, it’s great that Liverpool is now an official member.”
Dr Alexandre Ceccaldi, ETPN General Secretary commented: “I would second those remarks and add that we are very much looking to Liverpool hosting the NME23 conference on June 19-22, 2023, so that we can provide our community with outstanding networking capacities, discover new ways to work together, and enjoy this exciting city.”
Useful links:
https://etp-nanomedicine.eu/
https://www.britishsocietynanomedicine.org/